Skip to content
★ Sign in to follow
VS

Viktor Siewertz

IRLAB Theraoeutics AB
Total declarations
7
Company
1
▲ Purchases (6 ops.)
€50k
▼ Sales (1 ops.)
€132

Latest filing published 13 May 2024 for IRLAB Theraoeutics AB, €5,814.

Filing timeline

BuySale
Viktor Siewertz

Insider track record

Disclosed buys
6
Disclosed sells
1
Signal history

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Viktor Siewertz: trading record in brief

This profile gathers the share dealings of Viktor Siewertz in IRLAB Theraoeutics AB. In total, 7 filings cover trades dated from 10 September 2021 to 13 May 2024.

The open-market side counts 6 purchases for €50k alongside 1 sale for €132. Netting one side against the other leaves €50k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2024 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €8,425. 1 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 13 May 2024 with an open-market purchase (€5,814) in IRLAB Theraoeutics AB. The median gap between trade and publication is zero days: most filings appear on the same day. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Viktor Siewertz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesIRLAB Theraoeutics AB
    68,037 SEK32FI-SE
    5,000 shares@ SEK 13.607411.6% of flowAktieISIN SE0012675361FI:csv-f0fb9f61c8e2453063a9
    Canonical exit: 11 Aug 2024 (T+90)
  • ▼
    Ekonomichef/finanschef/finansdirektörExecutivesIRLAB Theraoeutics AB
    1,408 SEK19FI-SE
    40 shares@ SEK 35.200.3% of flowAktieISIN SE0012675361FI:csv-2988bf1c4bd385cec15e
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesIRLAB Theraoeutics AB
    1,420 SEK19FI-SE
    40 shares@ SEK 35.500.3% of flowAktieISIN SE0012675361FI:csv-969a2c4dfe96bf4822af
    Canonical exit: 28 Nov 2022 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesIRLAB Theraoeutics AB
    116,790 SEK22FI-SE
    3,000 shares@ SEK 38.9325.2% of flowAktieISIN SE0012675361FI:csv-b4d950925d1984d19175
    Canonical exit: 25 Aug 2022 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesIRLAB Theraoeutics AB
    120,480 SEK22FI-SE
    3,000 shares@ SEK 40.1626.1% of flowAktieISIN SE0012675361FI:csv-161f2174320fb000684d
    Canonical exit: 28 Aug 2022 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesIRLAB Theraoeutics AB
    170,370 SEK23FI-SE
    4,500 shares@ SEK 37.8637.0% of flowAktieISIN SE0012675361FI:csv-79ab7816eb726c7c6332
    Canonical exit: 29 Aug 2022 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesIRLAB Theraoeutics AB
    52,300 SEK20FI-SE
    1,000 shares@ SEK 52.3010.3% of flowAktieISIN SE0012675361FI:csv-2b1e941e6648a9802913
    Canonical exit: 9 Dec 2021 (T+90)

7 of 7 declarations